Axovant Sciences

All the email addresses found for axovant.com

15 email addresses found for axovant.com

Most common pattern: {first}-{last}@axovant.com

15 email addresses

Alexander Nguyen a**[email protected]	2 sources
http://axovant.com/responsibility/resources-compliance-personnel March 3, 2017 http://investors.axovant.com/node/7041/html March 3, 2018

Jonathan Neely

j**[email protected]

9 sources

http://biospace.com/article/releases/axovant-to-move-stock-exchange-listing-to-nasdaq- October 10, 2017
http://investors.axovant.com/news-releases/news-release-details/axovant-present-key-intepirdine-and-nelotanserin-data-alzheimers October 10, 2017
http://investors.axovant.com/news-releases/news-release-details/fda-grants-fast-track-designation-axovants-nelotanserin-visual October 10, 2017
http://investors.axovant.com/news-releases/news-release-details/new-preclinical-data-intepirdine-suggests-potential September 9, 2017
http://investors.axovant.com/node/7131/html October 10, 2017
http://investors.axovant.com/node/7211/html September 9, 2017
http://life-sciences-germany.com/news/roivant-axovant-negative-ph3-sciences-gmbh-group-nasdaq-2001-111512.html November 11, 2017
http://prnewswire.com/news-releases/axovant-to-move-stock-exchange-listing-to-nasdaq-300507244.html February 2, 2018
http://prnewswire.com/news-releases/english-releases/axovant-announces-negative-topline-results-of-intepirdine-phase-3-mindset-trial-in-alzheimers-disease-300525711.html March 3, 2018

Samina Bari

s**[email protected]

9 sources

m**[email protected]

17 sources

http://alzheimersnewstoday.com/2015/10/07/axovant-screens-first-patients-in-phase-3-mindset-study-on-rvt-101-for-alzheimers-disease August 8, 2017
http://alzheimersweekly.com/2015/11/axovant-developing-2-drugs-3-programs.html November 11, 2016
http://benzinga.com/pressreleases/15/10/n5889669/axovant-sciences-announces-start-of-confirmatory-phase-3-mindset-study- March 3, 2017
http://benzinga.com/pressreleases/15/11/n5956087/axovant-announces-expansion-of-dementia-drug-development-pipeline-and-r March 3, 2017
http://benzinga.com/pressreleases/16/04/n7798980/axovant-sciences-to-present-at-the-goldman-sachs-alzheimers-symposium October 10, 2017
http://benzinga.com/pressreleases/16/08/n8353796/axovant-sciences-announces-expansion-of-dementia-pipeline-and-reports-f October 10, 2017
http://investors.axovant.com/investors/press-releases/2015/11-04-2015-213056230 April 4, 2016
http://investors.axovant.com/investors/press-releases/2016/02-09-2016-211806073 April 4, 2016
http://investors.axovant.com/investors/press-releases/2016/02-23-2016-213138995 April 4, 2016
http://investors.axovant.com/investors/press-releases/2016/04-04-2016-213134416 April 4, 2016
http://investors.axovant.com/investors/press-releases/2016/27-01-2016 April 4, 2016
http://prnewswire.com/news-releases/axovant-sciences-announces-2015-fiscal-year-end-financial-results-and-corporate-updates-300279933.html October 10, 2017
http://prnewswire.com/news-releases/axovant-sciences-announces-expansion-of-dementia-pipeline-and-reports-financial-results-for-the-first-fiscal-quarter-ended-june-30-2016-300313586.html September 9, 2017
http://prnewswire.com/news-releases/axovant-sciences-to-present-at-the-goldman-sachs-alzheimers-symposium-300245720.html October 10, 2017
http://prnewswire.com/news-releases/axovant-sciences-to-present-at-upcoming-investor-conferences-300172507.html August 8, 2017
http://prnewswire.com/news-releases/axovant-sciences-to-present-at-upcoming-investor-conferences-300210510.html May 5, 2017
http://satprnews.com/2016/11/07/axovant-sciences-announces-dementia-pipeline-updates-and-reports-financial-results-for-the-second-fiscal-quarter-and-first-half-ended-september-30-2016 March 3, 2017

h**[email protected]

17 sources

http://ariva.de/news/axovant-sciences-announces-dementia-pipeline-updates-and-6039321 August 8, 2017
http://axovant.com/clinical-trials/headway-dlb September 9, 2016
http://benzinga.com/pressreleases/16/08/n8353796/axovant-sciences-announces-expansion-of-dementia-pipeline-and-reports-f October 10, 2017
http://benzinga.com/pressreleases/16/09/n8493973/axovant-sciences-receives-fda-fast-track-designation-for-intepirdine-as July 7, 2017
http://biznewsindex.com/article/axovant-sciences-announces-dementia-pipeline-updates-and-reports-financial-results-for-the-third-fiscal-quarter-and-nine-months-ended-december-31-2016 February 2, 2017
http://investors.axovant.com/investors/press-releases/2016/02-09-2016-211806073 April 4, 2016
http://investors.axovant.com/investors/press-releases/2016/02-23-2016-213138995 April 4, 2016
http://investors.axovant.com/investors/press-releases/2016/06-06-2016 August 8, 2016
http://investors.axovant.com/investors/press-releases/2016/11-07-2016-211717960 December 12, 2016
http://investors.axovant.com/investors/press-releases/2017/02-14-2017-211521196 April 4, 2017
http://medindia.net/health-press-release/axovant-sciences-receives-fda-fast-track-designation-for-intepirdine-as-an-investigational-treatment-for-dementia-with-lewy-bodies-301057-1.htm March 3, 2017
http://prnewswire.com/news-releases/axovant-sciences-announces-2015-fiscal-year-end-financial-results-and-corporate-updates-300279933.html October 10, 2017
http://prnewswire.com/news-releases/axovant-sciences-announces-expansion-of-dementia-pipeline-and-reports-financial-results-for-the-first-fiscal-quarter-ended-june-30-2016-300313586.html September 9, 2017
http://prnewswire.com/news-releases/axovant-sciences-receives-fda-fast-track-designation-for-intepirdine-as-an-investigational-treatment-for-dementia-with-lewy-bodies-300333734.html July 7, 2017
http://prnewswire.com/news-releases/axovant-sciences-to-present-at-upcoming-investor-conference-300224860.html November 11, 2017
http://satprnews.com/2016/11/07/axovant-sciences-announces-dementia-pipeline-updates-and-reports-financial-results-for-the-second-fiscal-quarter-and-first-half-ended-september-30-2016 March 3, 2017
http://techtrend24.com/axovant-sciences-announces-dementia-pipeline-updates-and-reports-financial-results-for-the-third-fiscal-quarter August 8, 2017

i**[email protected]

9 sources

http://axovant.com/contact-us September 9, 2015
http://axovant.com/contact-us/ September 9, 2015
http://axovant.com/privacy-policy September 9, 2015
http://axovant.com/privacy-policy/ September 9, 2015
http://axovant.com/terms-of-use May 5, 2016
http://biodirection.com/contact-us September 9, 2015
http://crueltyfreeinvesting.org/companies/axovant-sciences-ltd October 10, 2017
http://investors.axovant.com/investors/email-alerts April 4, 2016
http://roivant.com/contact-us February 2, 2016

i**[email protected]	1 source
http://axovant.com/responsibility/medical-education November 11, 2017

c**[email protected]	4 sources
http://axovant.com/about/contact-us/careers March 3, 2017 http://axovant.com/careers October 10, 2017 http://axovant.com/careers/position November 11, 2017 http://axovant.com/contact-us/careers January 1, 2017

m**[email protected]	1 source
http://cnbc.com/2017/11/02/globe-newswire-axovant-announces-second-fiscal-quarter-financial-results-and-corporate-updates.html February 2, 2018

i**[email protected]	1 source
http://cnbc.com/2017/11/02/globe-newswire-axovant-announces-second-fiscal-quarter-financial-results-and-corporate-updates.html February 2, 2018

Show more results

5 more results for axovant.com. Sign up or log in to access the full results.

Add the leading solution to find professional email addresses to your toolkit.

Hunter is already trusted by more than 800,000 professionals to build more connections and grow their business. Start today and get 100 free searches/month..

Create a free account

Already have an account? Sign in

Create a free account

Already have an account? Sign in

More information about axovant.com

Language of the website: English

Main technologies used:

CMS: WordPress
Marketing Automation: Yoast SEO
Programming Language: PHP